1. Home
  2. VTRS vs BROS Comparison

VTRS vs BROS Comparison

Compare VTRS & BROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTRS
  • BROS
  • Stock Information
  • Founded
  • VTRS 1961
  • BROS 1992
  • Country
  • VTRS United States
  • BROS United States
  • Employees
  • VTRS N/A
  • BROS N/A
  • Industry
  • VTRS Medicinal Chemicals and Botanical Products
  • BROS Restaurants
  • Sector
  • VTRS Health Care
  • BROS Consumer Discretionary
  • Exchange
  • VTRS Nasdaq
  • BROS Nasdaq
  • Market Cap
  • VTRS 9.0B
  • BROS 7.6B
  • IPO Year
  • VTRS N/A
  • BROS 2021
  • Fundamental
  • Price
  • VTRS $8.77
  • BROS $63.41
  • Analyst Decision
  • VTRS Hold
  • BROS Strong Buy
  • Analyst Count
  • VTRS 4
  • BROS 14
  • Target Price
  • VTRS $10.50
  • BROS $77.93
  • AVG Volume (30 Days)
  • VTRS 13.8M
  • BROS 2.6M
  • Earning Date
  • VTRS 05-08-2025
  • BROS 05-07-2025
  • Dividend Yield
  • VTRS 5.47%
  • BROS N/A
  • EPS Growth
  • VTRS N/A
  • BROS 109.32
  • EPS
  • VTRS N/A
  • BROS 0.38
  • Revenue
  • VTRS $14,330,200,000.00
  • BROS $1,361,068,000.00
  • Revenue This Year
  • VTRS N/A
  • BROS $26.07
  • Revenue Next Year
  • VTRS $1.20
  • BROS $23.53
  • P/E Ratio
  • VTRS N/A
  • BROS $165.03
  • Revenue Growth
  • VTRS N/A
  • BROS 30.42
  • 52 Week Low
  • VTRS $6.85
  • BROS $26.96
  • 52 Week High
  • VTRS $13.55
  • BROS $86.88
  • Technical
  • Relative Strength Index (RSI)
  • VTRS 57.48
  • BROS 55.75
  • Support Level
  • VTRS $8.47
  • BROS $58.20
  • Resistance Level
  • VTRS $9.57
  • BROS $65.14
  • Average True Range (ATR)
  • VTRS 0.30
  • BROS 2.54
  • MACD
  • VTRS 0.15
  • BROS 0.57
  • Stochastic Oscillator
  • VTRS 59.39
  • BROS 79.62

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

About BROS Dutch Bros Inc.

Dutch Bros Inc is an operator and franchisor of drive-thru coffee shops that are focused on serving hand-crafted beverages. The company's hand-crafted beverage-focused lineup features hot and cold espresso-based beverages, cold brew coffee products, proprietary energy drinks, tea, lemonade, smoothies and other beverages. The company has two reportable operating segments Company-operated shops and Franchising. It derives maximum revenue from Company operated shops.

Share on Social Networks: